Cargando…
Pharmacological enhancement of memory or cognition in normal subjects
The possibility of expanding memory or cognitive capabilities above the levels in high functioning individuals is a topic of intense discussion among scientists and in society at large. The majority of animal studies use behavioral endpoint measures; this has produced valuable information but limite...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033242/ https://www.ncbi.nlm.nih.gov/pubmed/24904313 http://dx.doi.org/10.3389/fnsys.2014.00090 |
_version_ | 1782317795449503744 |
---|---|
author | Lynch, Gary Cox, Conor D. Gall, Christine M. |
author_facet | Lynch, Gary Cox, Conor D. Gall, Christine M. |
author_sort | Lynch, Gary |
collection | PubMed |
description | The possibility of expanding memory or cognitive capabilities above the levels in high functioning individuals is a topic of intense discussion among scientists and in society at large. The majority of animal studies use behavioral endpoint measures; this has produced valuable information but limited predictability for human outcomes. Accordingly, several groups are pursuing a complementary strategy with treatments targeting synaptic events associated with memory encoding or forebrain network operations. Transcription and translation figure prominently in substrate work directed at enhancement. Notably, the question of why new proteins would be needed for a now-forming memory given that learning-driven synthesis presumably occurred throughout the immediate past has been largely ignored. Despite this conceptual problem, and some controversy, recent studies have reinvigorated the idea that selective gene manipulation is a plausible route to enhancement. Efforts to improve memory by facilitating synaptic encoding of information have also progressed, in part due of breakthroughs on mechanisms that stabilize learning-related, long-term potentiation (LTP). These advances point to a reductionistic hypothesis for a diversity of experimental results on enhancement, and identify under-explored possibilities. Cognitive enhancement remains an elusive goal, in part due to the difficulty of defining the target. The popular view of cognition as a collection of definable computations seems to miss the fluid, integrative process experienced by high functioning individuals. The neurobiological approach obviates these psychological issues to directly test the consequences of improving throughput in networks underlying higher order behaviors. The few relevant studies testing drugs that selectively promote excitatory transmission indicate that it is possible to expand cortical networks engaged by complex tasks and that this is accompanied by capabilities not found in normal animals. |
format | Online Article Text |
id | pubmed-4033242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-40332422014-06-05 Pharmacological enhancement of memory or cognition in normal subjects Lynch, Gary Cox, Conor D. Gall, Christine M. Front Syst Neurosci Neuroscience The possibility of expanding memory or cognitive capabilities above the levels in high functioning individuals is a topic of intense discussion among scientists and in society at large. The majority of animal studies use behavioral endpoint measures; this has produced valuable information but limited predictability for human outcomes. Accordingly, several groups are pursuing a complementary strategy with treatments targeting synaptic events associated with memory encoding or forebrain network operations. Transcription and translation figure prominently in substrate work directed at enhancement. Notably, the question of why new proteins would be needed for a now-forming memory given that learning-driven synthesis presumably occurred throughout the immediate past has been largely ignored. Despite this conceptual problem, and some controversy, recent studies have reinvigorated the idea that selective gene manipulation is a plausible route to enhancement. Efforts to improve memory by facilitating synaptic encoding of information have also progressed, in part due of breakthroughs on mechanisms that stabilize learning-related, long-term potentiation (LTP). These advances point to a reductionistic hypothesis for a diversity of experimental results on enhancement, and identify under-explored possibilities. Cognitive enhancement remains an elusive goal, in part due to the difficulty of defining the target. The popular view of cognition as a collection of definable computations seems to miss the fluid, integrative process experienced by high functioning individuals. The neurobiological approach obviates these psychological issues to directly test the consequences of improving throughput in networks underlying higher order behaviors. The few relevant studies testing drugs that selectively promote excitatory transmission indicate that it is possible to expand cortical networks engaged by complex tasks and that this is accompanied by capabilities not found in normal animals. Frontiers Media S.A. 2014-05-20 /pmc/articles/PMC4033242/ /pubmed/24904313 http://dx.doi.org/10.3389/fnsys.2014.00090 Text en Copyright © 2014 Lynch, Cox and Gall. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Lynch, Gary Cox, Conor D. Gall, Christine M. Pharmacological enhancement of memory or cognition in normal subjects |
title | Pharmacological enhancement of memory or cognition in normal subjects |
title_full | Pharmacological enhancement of memory or cognition in normal subjects |
title_fullStr | Pharmacological enhancement of memory or cognition in normal subjects |
title_full_unstemmed | Pharmacological enhancement of memory or cognition in normal subjects |
title_short | Pharmacological enhancement of memory or cognition in normal subjects |
title_sort | pharmacological enhancement of memory or cognition in normal subjects |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033242/ https://www.ncbi.nlm.nih.gov/pubmed/24904313 http://dx.doi.org/10.3389/fnsys.2014.00090 |
work_keys_str_mv | AT lynchgary pharmacologicalenhancementofmemoryorcognitioninnormalsubjects AT coxconord pharmacologicalenhancementofmemoryorcognitioninnormalsubjects AT gallchristinem pharmacologicalenhancementofmemoryorcognitioninnormalsubjects |